They get paid from the BPs
250k patients/year in US is similar to 19231 scripts/wk. If I was Matt, I will cut price to half for getting prefer status and getting about 100k scripts/wk (~1M patients/yr)
You state that you own 37K shares. But the way you do making people thinking you are shorts.
No connection between good CEO and Nobel Prize, Period.
I prefer to know about termination agreement and the content of SNY & Mannkind agreement filed in CTO
Can you send me his email address ? Thanks in forward
I vote for splitting. Mannkind need to unlock the real values
- "....until MannKind begins to distribute Afrezza during the third quarter." I hope Mankind will get good deals with PBMs
- " ...In the coming weeks, we will roll out more information about our commercial team for Afrezza, the resources that we are designing for patients and physicians, and our plans for the future." Partners , Sale team, etc....
I don't think it's a big deal if all shorts covering (incl. naked shorts) and all Call option exercised. The pps can be up to more than $50 level and Mannkind just sell about 10% (may be less) of outstanding shares to fund about $500M for general purposes. I had a topic talking about that, but some how Yahoo deleted it for no reason.
Sentiment: Strong Buy